Vivo Opportunity group (NASDAQ: ENTX) discloses 12.3M-share holding in Entera Bio
Rhea-AI Filing Summary
Entera Bio Ltd. has a new large shareholder group led by Vivo Opportunity entities. Vivo Opportunity, LLC may be deemed to beneficially own 11,817,401 Ordinary Shares, representing 6.9% of Entera Bio’s Ordinary Shares outstanding. These shares are held through Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P., and Vivo Opportunity Co-Invest (Cycle 3), L.P.
Vivo Opportunity Cayman, LLC may be deemed to beneficially own an additional 437,500 Ordinary Shares, or 0.3% of the class, held by Vivo Opportunity Cayman Fund, L.P. The ownership percentages are based on 172,251,411 Ordinary Shares outstanding, which includes 122,961,215 Ordinary Shares issued in a private placement completed on July 28, 2026. Each Vivo entity reports sole voting and dispositive power over its respective holdings.
Positive
- None.
Negative
- None.
Key Figures
Vivo Opportunity, LLC beneficial ownership: 11,817,401 Ordinary Shares
Vivo Opportunity, LLC percent of class: 6.9%
Vivo Opportunity Cayman, LLC beneficial ownership: 437,500 Ordinary Shares
+4 more
7 metrics
Vivo Opportunity, LLC beneficial ownership
11,817,401 Ordinary Shares
Shares that Vivo Opportunity, LLC may be deemed to beneficially own
Vivo Opportunity, LLC percent of class
6.9%
Percentage of Entera Bio Ordinary Shares attributed to Vivo Opportunity, LLC
Vivo Opportunity Cayman, LLC beneficial ownership
437,500 Ordinary Shares
Shares that Vivo Opportunity Cayman, LLC may be deemed to beneficially own
Vivo Opportunity Cayman, LLC percent of class
0.3%
Percentage of Entera Bio Ordinary Shares attributed to Vivo Opportunity Cayman, LLC
Total shares outstanding
172,251,411 Ordinary Shares
Ordinary Shares outstanding after including the July 28, 2026 private placement
Private placement shares issued
122,961,215 Ordinary Shares
Ordinary Shares issued in the private placement on July 28, 2026
Shares outstanding pre-private placement
49,290,196 Ordinary Shares
Ordinary Shares outstanding immediately prior to the private placement
Key Terms
beneficially own, dispositive power, Schedule 13G, private placement, +1 more
5 terms
beneficially own financial
"may be deemed to beneficially own an aggregate of 11,817,401 shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
dispositive power financial
"Sole Dispositive Power 11,817,401.00 8 | Shared Dispositive Power 0.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Schedule 13G regulatory
"The percentages reported in this Item 4(b) are based on 172,251,411 Ordinary Shares"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
private placement financial
"Ordinary Shares issued in the Private Placement, as disclosed in the Securities Purchase Agreement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
general partner financial
"Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P."
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What percentage of Entera Bio (ENTX) does Vivo Opportunity, LLC report owning?
Vivo Opportunity, LLC may be deemed to beneficially own 11,817,401 Ordinary Shares of Entera Bio, representing 6.9% of the outstanding Ordinary Shares. These are held through three affiliated limited partnerships listed in the Schedule 13G filing.
What is Vivo Opportunity Cayman, LLC’s reported stake in Entera Bio (ENTX)?
Vivo Opportunity Cayman, LLC may be deemed to beneficially own 437,500 Ordinary Shares of Entera Bio, equal to 0.3% of the class. These shares are held of record by Vivo Opportunity Cayman Fund, L.P., for which it acts as general partner.
Which entities are included in the Vivo group reporting holdings in Entera Bio (ENTX)?
The reporting group includes Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P., Vivo Opportunity Co-Invest (Cycle 3), L.P., Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P. and Vivo Opportunity Cayman, LLC, each listing its own shareholdings and control structure.
How is the Entera Bio (ENTX) private placement reflected in this ownership filing?
Ownership percentages are calculated using a share count that includes a private placement closed on July 28, 2026. The total 172,251,411 shares outstanding includes 122,961,215 Ordinary Shares issued in that private placement, as referenced in a Securities Purchase Agreement.